BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26486345)

  • 1. Microbubbles and Ultrasound: Therapeutic Applications in Diabetic Nephropathy.
    Cao WJ; Matkar PN; Chen HH; Mofid A; Leong-Poi H
    Adv Exp Med Biol; 2016; 880():309-30. PubMed ID: 26486345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications in progressive diabetic nephropathy.
    Leong-Poi H
    Semin Nephrol; 2012 Sep; 32(5):494-504. PubMed ID: 23062991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-targeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats.
    Wu S; Li L; Wang G; Shen W; Xu Y; Liu Z; Zhuo Z; Xia H; Gao Y; Tan K
    Int J Nanomedicine; 2014; 9():5639-51. PubMed ID: 25516709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-mediated microbubble destruction increases renal interstitial capillary permeability in early diabetic nephropathy rats.
    Zhang Y; Ye C; Xu Y; Dong X; Li J; Liu R; Gao Y
    Ultrasound Med Biol; 2014 Jun; 40(6):1273-81. PubMed ID: 24613211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Homing Ability and Retention of Bone Marrow Stromal Cells to Diabetic Nephropathy by Microbubble-Mediated Diagnostic Ultrasound Irradiation.
    Wang G; Zhuo Z; Yang B; Wu S; Xu Y; Liu Z; Tan K; Xia H; Wang X; Zou L; Gan L; Gao Y
    Ultrasound Med Biol; 2015 Nov; 41(11):2977-89. PubMed ID: 26318561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy.
    Yue T; Xu HL; Chen PP; Zheng L; Huang Q; Sheng WS; Zhuang YD; Jiao LZ; Chi TT; ZhuGe DL; Liu JJ; Zhao YZ; Lan L
    Int J Pharm; 2017 Aug; 528(1-2):664-674. PubMed ID: 28642201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospect of ultrasound-mediated gene delivery in cardiovascular applications.
    Chen HH; Matkar PN; Afrasiabi K; Kuliszewski MA; Leong-Poi H
    Expert Opin Biol Ther; 2016 Jun; 16(6):815-26. PubMed ID: 27063021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives.
    Panje CM; Wang DS; Willmann JK
    Invest Radiol; 2013 Nov; 48(11):755-69. PubMed ID: 23697924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer.
    Alter J; Sennoga CA; Lopes DM; Eckersley RJ; Wells DJ
    Ultrasound Med Biol; 2009 Jun; 35(6):976-84. PubMed ID: 19285783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Ultrasound-Targeted Microbubble Destruction-Mediated Exogenous Gene Transfer in Treating Various Renal Diseases.
    Huang S; Ren Y; Wang X; Lazar L; Ma S; Weng G; Zhao J
    Hum Gene Ther; 2019 Feb; 30(2):127-138. PubMed ID: 30205715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound.
    Rahim AA; Taylor SL; Bush NL; ter Haar GR; Bamber JC; Porter CD
    J Gene Med; 2006 Nov; 8(11):1347-57. PubMed ID: 16981246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of contrast agents to ultrasound.
    Sboros V
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1117-36. PubMed ID: 18486270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound targeted microbubble destruction for drug and gene delivery.
    Mayer CR; Geis NA; Katus HA; Bekeredjian R
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1121-38. PubMed ID: 18817517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy -- a multifaceted target of new therapies.
    Choudhury D; Tuncel M; Levi M
    Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induction by ultrasound and microbubble mediated drug delivery and gene therapy.
    Chen ZY; Wang YX; Zhao YZ; Yang F; Liu JB; Lin Y; Liao JY; Liao YY; Zhou QL
    Curr Mol Med; 2014; 14(6):723-36. PubMed ID: 25088226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular drug delivery with ultrasound and microbubbles.
    Unger E; Porter T; Lindner J; Grayburn P
    Adv Drug Deliv Rev; 2014 Jun; 72():110-26. PubMed ID: 24524934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery.
    Chen ZY; Yang F; Lin Y; Zhang JS; Qiu RX; Jiang L; Zhou XX; Yu JX
    Curr Gene Ther; 2013 Aug; 13(4):250-74. PubMed ID: 23721204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.